Vimarsana
Biggest News Aggregation in the World

Page 32 - Valuating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valuating Today - Breaking & Trending Today

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating JZP150 for Once-Daily Treatment of Adults with Post-Traumatic Stress Disorder - Vimarsana News

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating JZP150 for Once-Daily Treatment of Adults with Post-Traumatic Stress Disorder

U.S. FDA granted JZP150 Fast Track designation in PTSD, underscoring the unmet needs of patients If approved, JZP150 would become the first new drug approved in 20 years for patients

Bellerophon Therapeutics, Inc. Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of Inopulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis - Vimarsana News

Bellerophon Therapeutics, Inc. Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of Inopulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis

Bellerophon Therapeutics, Inc. announced positive top-line data from a recently completed Phase 2 dose escalation study evaluating the acute hemodynamic benefit of INOpulse® via right heart... | December 19, 2021

Continuously evaluating threats from Pakistan, China: IAF chief - Vimarsana News

Continuously evaluating threats from Pakistan, China: IAF chief

Indian Air Force (IAF) chief Air Chief Marshal VR Chaudhari said India is continuously evaluating threats from Pakistan and China, adding that disengagement has taken place in certain areas in Ladakh but complete disengagement with Beijing has not taken place.

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor - Vimarsana News

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor

DUBLIN, Dec. 15, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety

Former Boeing pilot says FAA official called him 'scapegoat' - Vimarsana News

Former Boeing pilot says FAA official called him 'scapegoat'

A former chief technical pilot for Boeing Co charged with fraud for deceiving federal regulators evaluating the company's 737 MAX jet says a Federal Aviation Administration official called him a... | December 14, 2021